# Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries

> **NCT06453681** · PHASE4 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 60 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **OTHER:** bilateral PECS
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT06453681
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-05-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06453681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06453681, "Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06453681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*